世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Neurosurgery Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurosurgery Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-203... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Neurosurgery Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. This report aims to provide a comprehensive presentation of the global market for Neurosurgery Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neurosurgery Drug by region & country, by Type, and by Application. The Neurosurgery Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurosurgery Drug. Market Segmentation By Company Pfizer AstraZeneca Biogen Jhonson & Jhonson ABBVIE Takeda Pharmaceuticals UCB IPSEN Standigm BlueStar Genomic Tonix Pharmaceuticals BlackThorn Therapeutics Quentrix Wren Pharmaceuticals Segment by Type Tablets Solution Capsules Others Segment by Application Hospital Clinic Others By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Neurosurgery Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Neurosurgery Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Neurosurgery Drug in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Neurosurgery Drug Product Introduction 1.2 Global Neurosurgery Drug Market Size Forecast 1.2.1 Global Neurosurgery Drug Sales Value (2020-2031) 1.2.2 Global Neurosurgery Drug Sales Volume (2020-2031) 1.2.3 Global Neurosurgery Drug Sales Price (2020-2031) 1.3 Neurosurgery Drug Market Trends & Drivers 1.3.1 Neurosurgery Drug Industry Trends 1.3.2 Neurosurgery Drug Market Drivers & Opportunity 1.3.3 Neurosurgery Drug Market Challenges 1.3.4 Neurosurgery Drug Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Neurosurgery Drug Players Revenue Ranking (2024) 2.2 Global Neurosurgery Drug Revenue by Company (2020-2025) 2.3 Global Neurosurgery Drug Players Sales Volume Ranking (2024) 2.4 Global Neurosurgery Drug Sales Volume by Company Players (2020-2025) 2.5 Global Neurosurgery Drug Average Price by Company (2020-2025) 2.6 Key Manufacturers Neurosurgery Drug Manufacturing Base and Headquarters 2.7 Key Manufacturers Neurosurgery Drug Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Neurosurgery Drug 2.9 Neurosurgery Drug Market Competitive Analysis 2.9.1 Neurosurgery Drug Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Neurosurgery Drug Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Tablets 3.1.2 Solution 3.1.3 Capsules 3.1.4 Others 3.2 Global Neurosurgery Drug Sales Value by Type 3.2.1 Global Neurosurgery Drug Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Neurosurgery Drug Sales Value, by Type (2020-2031) 3.2.3 Global Neurosurgery Drug Sales Value, by Type (%) (2020-2031) 3.3 Global Neurosurgery Drug Sales Volume by Type 3.3.1 Global Neurosurgery Drug Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Neurosurgery Drug Sales Volume, by Type (2020-2031) 3.3.3 Global Neurosurgery Drug Sales Volume, by Type (%) (2020-2031) 3.4 Global Neurosurgery Drug Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospital 4.1.2 Clinic 4.1.3 Others 4.2 Global Neurosurgery Drug Sales Value by Application 4.2.1 Global Neurosurgery Drug Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Neurosurgery Drug Sales Value, by Application (2020-2031) 4.2.3 Global Neurosurgery Drug Sales Value, by Application (%) (2020-2031) 4.3 Global Neurosurgery Drug Sales Volume by Application 4.3.1 Global Neurosurgery Drug Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Neurosurgery Drug Sales Volume, by Application (2020-2031) 4.3.3 Global Neurosurgery Drug Sales Volume, by Application (%) (2020-2031) 4.4 Global Neurosurgery Drug Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Neurosurgery Drug Sales Value by Region 5.1.1 Global Neurosurgery Drug Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Neurosurgery Drug Sales Value by Region (2020-2025) 5.1.3 Global Neurosurgery Drug Sales Value by Region (2026-2031) 5.1.4 Global Neurosurgery Drug Sales Value by Region (%), (2020-2031) 5.2 Global Neurosurgery Drug Sales Volume by Region 5.2.1 Global Neurosurgery Drug Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Neurosurgery Drug Sales Volume by Region (2020-2025) 5.2.3 Global Neurosurgery Drug Sales Volume by Region (2026-2031) 5.2.4 Global Neurosurgery Drug Sales Volume by Region (%), (2020-2031) 5.3 Global Neurosurgery Drug Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Neurosurgery Drug Sales Value, 2020-2031 5.4.2 North America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Neurosurgery Drug Sales Value, 2020-2031 5.5.2 Europe Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Neurosurgery Drug Sales Value, 2020-2031 5.6.2 Asia Pacific Neurosurgery Drug Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Neurosurgery Drug Sales Value, 2020-2031 5.7.2 South America Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Neurosurgery Drug Sales Value, 2020-2031 5.8.2 Middle East & Africa Neurosurgery Drug Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Neurosurgery Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Neurosurgery Drug Sales Value 6.2.1 Key Countries/Regions Neurosurgery Drug Sales Value, 2020-2031 6.2.2 Key Countries/Regions Neurosurgery Drug Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Neurosurgery Drug Sales Value, 2020-2031 6.3.2 United States Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Neurosurgery Drug Sales Value, 2020-2031 6.4.2 Europe Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Neurosurgery Drug Sales Value, 2020-2031 6.5.2 China Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.5.3 China Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Neurosurgery Drug Sales Value, 2020-2031 6.6.2 Japan Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Neurosurgery Drug Sales Value, 2020-2031 6.7.2 South Korea Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Neurosurgery Drug Sales Value, 2020-2031 6.8.2 Southeast Asia Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Neurosurgery Drug Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Neurosurgery Drug Sales Value, 2020-2031 6.9.2 India Neurosurgery Drug Sales Value by Type (%), 2024 VS 2031 6.9.3 India Neurosurgery Drug Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Information 7.1.2 Pfizer Introduction and Business Overview 7.1.3 Pfizer Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Pfizer Neurosurgery Drug Product Offerings 7.1.5 Pfizer Recent Development 7.2 AstraZeneca 7.2.1 AstraZeneca Company Information 7.2.2 AstraZeneca Introduction and Business Overview 7.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 AstraZeneca Neurosurgery Drug Product Offerings 7.2.5 AstraZeneca Recent Development 7.3 Biogen 7.3.1 Biogen Company Information 7.3.2 Biogen Introduction and Business Overview 7.3.3 Biogen Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Biogen Neurosurgery Drug Product Offerings 7.3.5 Biogen Recent Development 7.4 Jhonson & Jhonson 7.4.1 Jhonson & Jhonson Company Information 7.4.2 Jhonson & Jhonson Introduction and Business Overview 7.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Jhonson & Jhonson Neurosurgery Drug Product Offerings 7.4.5 Jhonson & Jhonson Recent Development 7.5 ABBVIE 7.5.1 ABBVIE Company Information 7.5.2 ABBVIE Introduction and Business Overview 7.5.3 ABBVIE Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 ABBVIE Neurosurgery Drug Product Offerings 7.5.5 ABBVIE Recent Development 7.6 Takeda Pharmaceuticals 7.6.1 Takeda Pharmaceuticals Company Information 7.6.2 Takeda Pharmaceuticals Introduction and Business Overview 7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Product Offerings 7.6.5 Takeda Pharmaceuticals Recent Development 7.7 UCB 7.7.1 UCB Company Information 7.7.2 UCB Introduction and Business Overview 7.7.3 UCB Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 UCB Neurosurgery Drug Product Offerings 7.7.5 UCB Recent Development 7.8 IPSEN 7.8.1 IPSEN Company Information 7.8.2 IPSEN Introduction and Business Overview 7.8.3 IPSEN Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 IPSEN Neurosurgery Drug Product Offerings 7.8.5 IPSEN Recent Development 7.9 Standigm 7.9.1 Standigm Company Information 7.9.2 Standigm Introduction and Business Overview 7.9.3 Standigm Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Standigm Neurosurgery Drug Product Offerings 7.9.5 Standigm Recent Development 7.10 BlueStar Genomic 7.10.1 BlueStar Genomic Company Information 7.10.2 BlueStar Genomic Introduction and Business Overview 7.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 BlueStar Genomic Neurosurgery Drug Product Offerings 7.10.5 BlueStar Genomic Recent Development 7.11 Tonix Pharmaceuticals 7.11.1 Tonix Pharmaceuticals Company Information 7.11.2 Tonix Pharmaceuticals Introduction and Business Overview 7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Product Offerings 7.11.5 Tonix Pharmaceuticals Recent Development 7.12 BlackThorn Therapeutics 7.12.1 BlackThorn Therapeutics Company Information 7.12.2 BlackThorn Therapeutics Introduction and Business Overview 7.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 BlackThorn Therapeutics Neurosurgery Drug Product Offerings 7.12.5 BlackThorn Therapeutics Recent Development 7.13 Quentrix 7.13.1 Quentrix Company Information 7.13.2 Quentrix Introduction and Business Overview 7.13.3 Quentrix Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Quentrix Neurosurgery Drug Product Offerings 7.13.5 Quentrix Recent Development 7.14 Wren Pharmaceuticals 7.14.1 Wren Pharmaceuticals Company Information 7.14.2 Wren Pharmaceuticals Introduction and Business Overview 7.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Wren Pharmaceuticals Neurosurgery Drug Product Offerings 7.14.5 Wren Pharmaceuticals Recent Development 8 Industry Chain Analysis 8.1 Neurosurgery Drug Industrial Chain 8.2 Neurosurgery Drug Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Neurosurgery Drug Sales Model 8.5.2 Sales Channel 8.5.3 Neurosurgery Drug Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
